Skip to main content
Theratechnologies Inc. logo

Theratechnologies Inc. — Investor Relations & Filings

Ticker · THTX ISIN · CA88338H1001 LEI · 5493003Q78Q8VKGF1459 US Manufacturing
Open in API
Filings indexed 282 across all filing types
Latest filing 2025-12-01 Regulatory Filings
Country CA Canada
Listing US THTX

About Theratechnologies Inc.

https://www.theratech.com/

Theratechnologies Inc. is a biopharmaceutical company focused on developing and commercializing specialized therapies for unmet medical needs, primarily for people living with HIV. The company's main commercial products are Trogarzo® (ibalizumab-uiyk), an antiretroviral therapy, and EGRIFTA SV®/WR™ (tesamorelin), a treatment for the reduction of excess abdominal fat in adults with HIV-associated lipodystrophy. Its research and development pipeline is also centered on advancing treatments within the HIV field. In September 2025, the company completed its acquisition by Future Pak.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2025
Regulatory Filings
2025-12-01 English
15-12G
Regulatory Filings Classification · 100% confidence The document is a Form 15 filed with the SEC, titled 'Certification and Notice of Termination of Registration' under the Securities Exchange Act of 1934. It indicates termination or suspension of the duty to file reports. The document is short (1665 characters) and is a regulatory notice rather than a financial report or detailed filing. It does not contain financial statements or detailed management information. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and certifications.
2025-11-25 English
POS AM
Capital/Financing Update Classification · 95% confidence The document is titled 'Post-Effective Amendment No. 2 to Form F-3 Registration Statement' filed with the SEC. It discusses deregistration of unsold common shares following an acquisition and termination of offerings under the registration statement. The content is regulatory in nature, related to securities registration and deregistration, and does not contain financial statements or detailed financial data. It is a formal amendment filing related to capital structure changes but primarily serves as a regulatory update on the status of the registration statement and share offerings. This fits the category of Capital/Financing Update (CAP) because it involves changes in the registration and offering of securities post-acquisition, which affects the company's capital structure and financing activities.
2025-11-25 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-11-14 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-09-29 English
Delisting Announcement 2025
Delisting Announcement
2025-09-25 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.